Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Gross Profit Margin (Quarterly): -31.87K% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -31.87K% |
| March 31, 2024 | -9.67K% |
| December 31, 2023 | -4.98K% |
| September 30, 2023 | -21.73K% |
| June 30, 2023 | -9.50K% |
| March 31, 2023 | -1.62K% |
| December 31, 2022 | -3.73K% |
| September 30, 2022 | -2.39K% |
| June 30, 2022 | 35.79% |
| March 31, 2022 | -3.90K% |
| December 31, 2021 | 21.77% |
| September 30, 2021 | -790.9% |
| June 30, 2021 | -1.18K% |
| March 31, 2021 | -382.0% |
| December 31, 2020 | -334.7% |
| September 30, 2020 | 41.94% |
| June 30, 2020 | -506.5% |
| March 31, 2020 | -468.3% |
| December 31, 2019 | -251.8% |
| September 30, 2019 | -234.1% |
| June 30, 2019 | -236.5% |
| March 31, 2019 | -178.2% |
| December 31, 2018 | -148.2% |
| September 30, 2018 | -101.0% |
| June 30, 2018 | -247.3% |
| Date | Value |
|---|---|
| March 31, 2018 | -320.2% |
| December 31, 2017 | |
| September 30, 2017 | -303.7% |
| June 30, 2017 | -548.8% |
| March 31, 2017 | -364.5% |
| December 31, 2016 | 43.34% |
| September 30, 2016 | 69.74% |
| June 30, 2016 | -67.58% |
| March 31, 2016 | -60.72% |
| December 31, 2015 | -35.79% |
| September 30, 2015 | -45.46% |
| June 30, 2015 | -93.15% |
| March 31, 2015 | -102.9% |
| December 31, 2014 | 59.65% |
| September 30, 2014 | -21.30% |
| June 30, 2014 | -50.71% |
| March 31, 2014 | -56.54% |
| December 31, 2013 | 43.23% |
| September 30, 2013 | -200.9% |
| June 30, 2013 | -1.12K% |
| March 31, 2013 | -1.10K% |
| December 31, 2012 | -351.4% |
| September 30, 2012 | -413.3% |
| June 30, 2012 | -347.7% |
| March 31, 2012 | -380.5% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-31.87K%
Minimum
Jun 2024
41.94%
Maximum
Sep 2020
-4.91K%
Average
-1.18K%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 82.85% |
| Biomarin Pharmaceutical Inc | 74.73% |
| Catalyst Pharmaceuticals Inc | 87.45% |
| Sarepta Therapeutics Inc | 87.73% |
| Ocugen Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -58.30% |
| Return on Invested Capital | -163.9% |
| Profit Margin (Quarterly) | -57.56K% |
| Operating Margin (Quarterly) | -52.28K% |
| Return on Net Operating Assets | -360.6% |